This year’s influenza vaccines meant for pharmacists and GP practices across the UK are being shipped on time.
Manufacturers and suppliers, Seqirus, said on Thursday they were delivering over 11.5 million vaccine doses to the UK. The on-time delivery means healthcare professionals will be well prepared for the flu season.
The Fluad (adjuvanted trivalent influenza vaccine – aTIV) and Flucelvax Tetra (QIVc) would be delivered on time despite challenges faced by the delay in the World Health Organisation H3N2 strain announcement, the company said in a statement.
During last year’s flu season, aTIV was the only vaccine recommended for reimbursement by the NHS for the age group above 65 years.
The cell-based QIVc vaccine is currently recommended alongside egg-based quadrivalent flu vaccines (QIVe) for 18 to 64 years’ age group, alongside aTIV for those aged 65 years and over.
“The swift change over to aTIV for the entire 65+ population across the UK last season was a complex operation for all of us working on the front line of influenza prevention,” said Helen Concilia, UK Country Head, Seqirus.
“However, the hard work from GPs, practice nurses and practice managers was effort well placed as aTIV appears to have significantly reduced the risk of influenza and medical visits in older adults in 2018-19, as highlighted by recent Public Health England data,” she said.